1 year return (CAGR)
133.54%
Athira Pharma Inc Exchange (NASDAQ, USD)
ATHA
-
+0.16 (+2.13%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-36.13%
5 year return (CAGR)
-47.46%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
30.21M
Price/Sales
31.21
Ent value
12.58M
Price/Book
1.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
24.74%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 7.40 |
| Daily high | 7.93 |
| Daily low | 6.96 |
| Daily Volume | 53K |
| 1y analyst estimate | 4.00 |
| Beta | 2.80 |
| EPS (TTM) | -9.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ATHA | S&P500 | |
| Current price drop from All-time high | -77.67% | -4.77% |
| Highest price drop | -99.33% | -56.47% |
| Date of highest drop | 16 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -79.19% | -10.68% |
| Avg time to new high | 92 days | 12 days |
| Max time to new high | 1310 days | 1805 days |
News
No items found